FMC stock results due November 3, 2026, little changed pre-market
Published on 10/26/2026 at 08:09 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSCalendar dates guide the week
- The issuer's calendar schedules third-quarter results for November 3, 2026.
- The quarterly financial report is listed for November 6, 2026.
- FMC stock trades pre-market at EUR 40.45 at 8:06 a.m. CET at Lang & Schwarz on October 26, 2026, 0.02 percent below the Xetra close of October 23, 2026.
Fresenius Medical Care's investor calendar schedules its third-quarter 2026 results and conference call for November 3, 2026, according to the company's investor relations site. FMC stock trades pre-market at EUR 40.45 at 8:06 a.m. CET at Lang & Schwarz on October 26, 2026, 0.02 percent below the Xetra close of October 23, 2026 (EUR 40.46).
Results date on the investor calendar
The company calendar lists November 3, 2026, for the publication of third-quarter results and a conference call. It also schedules the quarterly financial report for November 6, 2026, according to the Fresenius Medical Care investor calendar.
Early trading at Lang & Schwarz
The indicated move is minus EUR 0.01 against Friday's Xetra closing level. The further course from the Xetra open at 9:00 a.m. CET is shown by the continuously updated real-time quote of FMC stock.
Business and scheduled events
Fresenius Medical Care operates in kidney care, including in-center hemodialysis, with its business centered on providing dialysis services and related care, according to its investor relations site. The calendar also lists an investor roadshow in London on November 4, 2026, another in Frankfurt on November 5, 2026, and the UBS Global Healthcare Conference on November 10, 2026. Market context: Market report DAX.
